Antimicrobial Agents Practice Questions

Q: Interferon gamma is used for the treatment of which condition?

Osteopetrosis. **Explanation:** The correct answer is **Osteopetrosis**. While the name "Interferon" often suggests antiviral therapy, it is crucial to distinguish between the different types of interferons and their specific clinical indications. **1. Why Osteopetrosis is correct:** Interferon-gamma (IFN-γ) is a Type II interferon. In **malignant infantile osteopetrosis**, there is a defect in osteoclast function leading to overly dense bones. IFN-γ works by increasing bone resorption and enhancing phagocyte activity. It helps by increasing the surface area for bone resorption and improving the immune response, thereby delaying disease progression. It is also the drug of choice for **Chronic Granulomatous Disease (CGD)** because it enhances the "oxidative burst" in neutrophils. **2. Why the other options are incorrect:** * **Hepatitis B and C (Options A, B, and D):** These viral infections are treated with **Interferon-alpha (IFN-α)**, which is a Type I interferon. IFN-α induces host cell enzymes that inhibit viral mRNA translation and degradation of viral RNA. IFN-gamma has relatively weak antiviral activity compared to IFN-alpha and is not used for these conditions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Interferon-alpha:** Used for Hepatitis B, Hepatitis C, Condyloma acuminata, Hairy cell leukemia, and Kaposi sarcoma. * **Interferon-beta:** Used primarily for **Multiple Sclerosis** (to reduce the frequency of relapses). * **Interferon-gamma:** Used for **Chronic Granulomatous Disease (CGD)** and **Osteopetrosis**. * **Common Side Effect:** All interferons commonly cause a "flu-like syndrome" (fever, chills, myalgia) shortly after administration.

Q: Which of the following anti-HIV drugs should never be given as rechallenge once a history of producing an allergic reaction with the drug is known?

Abacavir. **Explanation:** The correct answer is **Abacavir (Option B)**. Abacavir is associated with a severe, potentially life-threatening **Hypersensitivity Reaction (HSR)** in approximately 5–8% of patients. [1] This reaction is strongly linked to the presence of the **HLA-B*5701 allele**. [1] If a patient develops an allergic reaction to Abacavir, **rechallenge is strictly contraindicated** because it can trigger a rapid, more severe, and fatal systemic reaction (anaphylaxis or multi-organ failure) within hours. **Why the other options are incorrect:** * **Lamivudine (3TC) & Zidovudine (AZT):** These are Nucleoside Reverse Transcriptase Inhibitors (NRTIs). [2] While they have side effects (e.g., AZT causes bone marrow suppression and macrocytic anemia), they are not typically associated with the specific, fatal rechallenge-induced hypersensitivity seen with Abacavir. * **Nelfinavir:** This is a Protease Inhibitor (PI). Its primary side effect is diarrhea. While any drug can cause an allergy, it does not carry the "never rechallenge" black box warning associated with Abacavir’s genetic predisposition. **High-Yield Clinical Pearls for NEET-PG:** * **Mandatory Screening:** Always screen for **HLA-B*5701** before initiating Abacavir. [1] If positive, the drug should never be used. * **Clinical Presentation:** Abacavir HSR typically presents within the first 6 weeks of treatment with fever, rash, GI symptoms, and respiratory distress. * **Nevirapine (NNRTI):** Another anti-HIV drug known for severe skin reactions (Stevens-Johnson Syndrome), but the specific "rechallenge contraindication" based on HLA-linkage is most classically tested with Abacavir. * **Mnemonic:** "A-B-C" — **A**bacavir, **B**ad reaction, **C**ontraindicated to rechallenge.

Q: Which of the following binds to viral envelope glycoprotein preventing the conformational changes required for the fusion of viral and cellular membranes?

Enfuvirtide. **Explanation:** **Correct Option: C. Enfuvirtide** Enfuvirtide is a unique antiretroviral agent classified as a **Fusion Inhibitor**. Its mechanism of action involves binding to the **gp41** subunit of the viral envelope glycoprotein. By binding to this subunit, it prevents the necessary conformational changes required for the fusion of the HIV-1 envelope with the host cell membrane (CD4+ T-cell). Since the virus cannot fuse, it cannot enter the host cell. **Analysis of Incorrect Options:** * **A. Abacavir:** This is a Nucleoside Reverse Transcriptase Inhibitor (**NRTI**). It acts by inhibiting the viral reverse transcriptase enzyme, leading to DNA chain termination. It does not affect viral entry. * **B. Indinavir:** This is a **Protease Inhibitor (PI)**. It prevents the cleavage of the Gag-Pol polyprotein precursor, resulting in the production of immature, non-infectious virions. * **D. Oseltamivir:** This is a **Neuraminidase Inhibitor** used for Influenza A and B. It prevents the release of new virions from infected cells; it is not used for HIV. **High-Yield NEET-PG Pearls:** * **Route of Administration:** Enfuvirtide is the only antiretroviral administered **subcutaneously** (twice daily). * **Site of Action:** It targets **gp41**, whereas Maraviroc (another entry inhibitor) targets the host cell **CCR5 receptor**. * **Resistance:** Resistance to Enfuvirtide occurs via mutations in the *env* gene. * **Side Effects:** Local injection site reactions (nodules, erythema) are seen in almost 100% of patients.

Q: Which of the following drugs can be given in a case of combined gonococcal and nongonococcal cervicitis?

Azithromycin. ### Explanation **Concept:** Combined cervicitis involves two primary pathogens: *Neisseria gonorrhoeae* (Gonococcal) and *Chlamydia trachomatis* (Nongonococcal). To treat both simultaneously with a single agent, the drug must have efficacy against both Gram-negative cocci and intracellular organisms. **Why Azithromycin is Correct:** Azithromycin is a macrolide that inhibits protein synthesis (50S subunit). It is unique because it is highly effective against ***Chlamydia trachomatis*** (the most common cause of nongonococcal cervicitis) and, in a single high dose (2g), also covers ***Neisseria gonorrhoeae***. While resistance is increasing, it remains the classic "single-shot" answer for dual coverage in syndromic management. **Why Other Options are Incorrect:** * **Ceftriaxone (Option A):** This is the gold standard for *N. gonorrhoeae*. However, it has **no activity** against *Chlamydia* because *Chlamydia* lacks a typical peptidoglycan cell wall (the target of beta-lactams). * **Cefixime (Option D):** Like Ceftriaxone, it is a third-generation cephalosporin effective against Gonococcus but ineffective against Nongonococcal (Chlamydial) infections. * **Ciprofloxacin (Option C):** Fluoroquinolones were once used, but are no longer recommended as first-line therapy due to widespread high-level resistance in *N. gonorrhoeae*. **Clinical Pearls for NEET-PG:** * **CDC Current Guidelines:** Due to rising resistance, the current recommendation for Gonorrhea is **Ceftriaxone (500mg IM)**. If Chlamydia is not ruled out, add **Doxycycline (100mg BID for 7 days)**. * **Syndromic Management (WHO/NACO):** For urethral/cervical discharge (Grey Kit), the combination used is **Azithromycin (1g stat) + Cefixime (400mg stat)**. * **Drug of Choice for Chlamydia in Pregnancy:** Azithromycin is preferred over Doxycycline (which is contraindicated).

Q: What is the mechanism of action of Amantidine?

Inhibiting viral replication. **Mechanism of Action: Amantadine** Amantadine is an antiviral agent primarily used against the Influenza A virus. Its core mechanism involves **inhibiting viral replication** by targeting the viral **M2 protein**, an ion channel found on the viral envelope. 1. **Why Option A is correct:** After the virus enters the host cell via endocytosis, the M2 ion channel allows protons ($H^+$) to enter the virion. This acidification is essential for the "uncoating" process, where the viral RNA is released into the host cytoplasm. Amantadine blocks this M2 channel, preventing uncoating and subsequent viral replication. 2. **Why Options B, C, and D are incorrect:** Amantadine does not directly interfere with the enzymatic synthesis of nucleic acids (mRNA, tRNA, or RNA). Drugs like **Ribavirin** (inhibits RNA polymerase) or **Acyclovir** (inhibits DNA polymerase) act on synthesis pathways. Amantadine acts at an earlier stage of the viral life cycle (uncoating) rather than the transcription or translation phases. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Active only against **Influenza A**; Influenza B lacks the M2 protein and is inherently resistant. * **Parkinsonism:** Amantadine is also used in Parkinson’s disease because it increases **dopamine release** and inhibits its reuptake. * **Side Effects:** A classic board-favorite side effect is **Livedo Reticularis** (a purplish, net-like vascular discoloration of the skin) and ankle edema. * **Resistance:** Due to widespread resistance, it is no longer recommended as a first-line treatment for Influenza; Neuraminidase inhibitors (Oseltamivir) are preferred.

Q: Which of the following is not a 4-aminoquinolone?

Primaquine. ### Explanation The classification of antimalarial drugs based on their chemical structure is a high-yield topic for NEET-PG. The question asks to identify the drug that does **not** belong to the 4-aminoquinoline class. **1. Why Primaquine is the Correct Answer:** Primaquine is an **8-aminoquinoline**, not a 4-aminoquinoline. The numerical prefix refers to the position on the quinoline ring where the side chain is attached. * **Clinical Significance:** Unlike 4-aminoquinolines, Primaquine is unique because it acts on **exo-erythrocytic (tissue) stages** of *P. vivax* and *P. ovale* (hypnozoites), making it essential for preventing relapse (radical cure). It is also a potent gametocide for all species. **2. Analysis of Incorrect Options:** * **A. Chloroquine:** The prototype **4-aminoquinoline**. It is highly effective against erythrocytic stages of sensitive plasmodia but has no effect on latent tissue stages. * **B. Amodiaquine:** Another **4-aminoquinoline** chemically similar to chloroquine. It is often used in combination therapies (ACTs) in areas with chloroquine resistance. * **D. Mefloquine:** While it contains a quinoline ring, it is technically a **quinoline-methanol**. However, in many classification systems, it is grouped closer to the 4-aminoquinoline functional family (blood schizonticides) rather than the 8-aminoquinolines. **3. NEET-PG High-Yield Pearls:** * **G6PD Deficiency:** Always screen for G6PD deficiency before administering **Primaquine** or **Tafenoquine** (another 8-aminoquinoline), as they can cause life-threatening acute hemolysis. * **Drug of Choice:** Chloroquine remains the DOC for malaria in pregnancy (if sensitive). * **Cinchonism:** A classic side effect profile (tinnitus, dizziness, nausea) associated with Quinine (a quinoline-methanol). * **Radical Cure:** Defined as the total eradication of parasites from the body (Blood + Liver stages). Only 8-aminoquinolines achieve this for *P. vivax/ovale*.

Q: What is the most serious adverse effect of penicillin?

Anaphylaxis. **Explanation:** **Anaphylaxis** is the most serious and life-threatening adverse effect of penicillin. It is a **Type I Hypersensitivity reaction** mediated by IgE antibodies. When a sensitized individual is exposed to penicillin, it acts as a hapten, binding to proteins to trigger massive mast cell degranulation. This results in bronchospasm, laryngeal edema, and severe hypotension, which can be fatal within minutes if not treated immediately with **Adrenaline (1:1000 IM)**. **Analysis of Other Options:** * **Skin Rashes:** These are the *most common* adverse effects of penicillin (especially Maculopapular rashes), but they are generally not life-threatening. * **Jarisch-Herxheimer Reaction:** This occurs specifically during the treatment of **Syphilis** (Spirochetes) due to the sudden release of endotoxins and antigens from dying organisms. While distressing (fever, chills, headache), it is usually self-limiting and managed with aspirin. * **Convulsions:** Penicillins (especially Penicillin G) are neurotoxic and can cause seizures if given in very high doses or in patients with renal failure (due to accumulation). However, this is less frequent and generally less acutely fatal than anaphylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Pre-test:** Always perform a **Skin Sensitivity Test (SST)** before administering penicillin. However, a negative test does not 100% rule out future anaphylaxis. * **Cross-reactivity:** There is a 5-10% cross-reactivity between penicillins and **Cephalosporins**. Avoid cephalosporins in patients with a history of penicillin anaphylaxis. * **Drug of Choice for Anaphylaxis:** Adrenaline 0.5 mg (1:1000) IM in the anterolateral thigh.

Q: Which drugs are used in lepra reaction?

All of the above. Lepra reactions are immunologically mediated inflammatory episodes occurring during the course of leprosy. They are classified into Type 1 (Reversal Reaction) and Type 2 (Erythema Nodosum Leprosum - ENL). The management focuses on controlling inflammation and preventing nerve damage. **Why "All of the above" is correct:** The management of lepra reactions involves a variety of anti-inflammatory and immunomodulatory agents depending on the severity: * **Thalidomide (Option A):** This is the **drug of choice for severe Type 2 reactions (ENL)** [1]. It acts by inhibiting TNF-alpha and is highly effective, though strictly contraindicated in pregnancy due to its potent teratogenicity (phocomelia). * **Clofazimine (Option B):** Apart from its bactericidal action against *M. leprae*, clofazimine possesses significant anti-inflammatory properties [1]. It is used in the management of chronic ENL and helps in tapering steroid doses. * **Chloroquine (Option C):** While primarily an antimalarial, chloroquine has mild anti-inflammatory effects and is used as an adjuvant in mild to moderate ENL cases when steroids are to be avoided. **Clinical Pearls for NEET-PG:** 1. **Corticosteroids (Prednisolone):** These remain the **standard first-line treatment** for both Type 1 and Type 2 lepra reactions to prevent permanent nerve palsy. 2. **Type 1 Reaction:** A delayed hypersensitivity (Type IV) reaction; treated primarily with steroids. Thalidomide is **not** effective here. 3. **Type 2 Reaction (ENL):** An Arthus-type (Type III) immune-complex mediated reaction [1]. 4. **Other agents:** Methotrexate, Azathioprine, and Cyclosporine may be used as steroid-sparing agents in recalcitrant cases. 5. **Important Note:** MDT (Multi-Drug Therapy) should **never** be stopped during a lepra reaction.

Q: Regarding dihydroartemisinin pharmacokinetics, all are true except?

Has a long half-life. **Explanation:** Dihydroartemisinin (DHA) is the active metabolite of artemisinin derivatives (Artesunate, Artemether) and is also used as a standalone drug in Artemisinin-based Combination Therapy (ACT). **Why Option B is the correct answer (False statement):** Artemisinins are known for their **rapid onset of action** and **extremely short elimination half-lives**. Dihydroartemisinin has a half-life of approximately **45 minutes to 2 hours**. This rapid clearance is the reason why artemisinins cannot be used as monotherapy for short durations; they must be combined with a long-acting partner drug (e.g., Lumefantrine, Piperaquine) to prevent recrudescence. **Analysis of Incorrect Options (True statements):** * **Option A:** DHA is primarily metabolized by glucuronidation (UGT1A9 and UGT2B7). Clinical studies indicate that no significant dose adjustments are required in patients with renal or hepatic impairment. * **Option C:** The oral bioavailability of DHA is relatively low, estimated at around **30-45%**, due to its poor solubility and first-pass metabolism. * **Option D:** Artemisinins are known to induce their own metabolism (**autoinduction**) via the Cytochrome P450 system (specifically CYP2B6 and CYP3A4), which can lead to a decrease in plasma concentrations over repeated dosing. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Produces free radicals (via the endoperoxide bridge) that damage parasite proteins. * **Drug of Choice:** Artesunate (IV) is the drug of choice for **Severe Malaria**. * **Safe in Pregnancy:** Artemisinins are now considered safe for use in the **first trimester** of pregnancy (WHO updated guidelines). * **Key Side Effect:** Delayed post-artemisinin hemolytic anemia (PAHA) can occur 1–3 weeks after treatment.

Question 1

Interferon gamma is used for the treatment of which condition?

Accepted Answer

Osteopetrosis

Answer

Hepatitis B Virus (HBV) infection

Answer

Hepatitis C Virus (HCV) infection

Answer

Both HBV and HCV infections

Question 2

Which of the following anti-HIV drugs should never be given as rechallenge once a history of producing an allergic reaction with the drug is known?

Accepted Answer

Abacavir

Answer

Lamivudine

Answer

Zidovudine

Answer

Nelfinavir

Question 3

Which of the following binds to viral envelope glycoprotein preventing the conformational changes required for the fusion of viral and cellular membranes?

Accepted Answer

Enfuvirtide

Answer

Abacavir

Answer

Indinavir

Answer

Oseltamivir

Question 4

Which of the following drugs can be given in a case of combined gonococcal and nongonococcal cervicitis?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Ciprofloxacin

Answer

Cefixime

Question 5

What is the mechanism of action of Amantidine?

Accepted Answer

Inhibiting viral replication

Answer

Inhibiting mRNA synthesis

Answer

Inhibiting tRNA synthesis

Answer

Inhibiting RNA synthesis

Question 6

Which of the following is not a 4-aminoquinolone?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Amodiaquine

Answer

Mefloquine

Question 7

What is the most serious adverse effect of penicillin?

Accepted Answer

Anaphylaxis

Answer

Skin rashes

Answer

Jarish-Herxheimer reaction

Answer

Convulsion

Question 8

Which drugs are used in lepra reaction?

Accepted Answer

All of the above

Answer

Thalidomide

Answer

Clofazimine

Answer

Chloroquine

Question 9

Regarding dihydroartemisinin pharmacokinetics, all are true except?

Accepted Answer

Has a long half-life

Answer

Dose adjustment is not required in hepatic or renal failure

Answer

Oral bioavailability is around 30%

Answer

Autoinduction of metabolism

Question 10

Which of the following is not a semi-synthetic penicillin?

Accepted Answer

Penicillin G

Answer

Penicillin V

Answer

Methicillin

Answer

Amoxicillin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?